Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

New genetic markers for diagnosis of hepatitis C related hepatocellular carcinoma in Egyptian patients.

Saad Y, El-Serafy M, Eldin MS, Abdellatif Z, Khatab H, Elbaz T, Elgarem H.

J Gastrointestin Liver Dis. 2013 Dec;22(4):419-25.

2.

Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.

Yan D, He Q, Chen Y, Wang L, Zhang X.

J Clin Lab Anal. 2011;25(2):113-7. doi: 10.1002/jcla.20443.

PMID:
21438004
3.

Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.

Ibrahim GH, Mahmoud MA, Aly NM.

Mol Biol Rep. 2013 Dec;40(12):7069-75. doi: 10.1007/s11033-013-2829-3. Epub 2013 Nov 2.

PMID:
24186850
4.

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW.

Clin Cancer Res. 2007 Feb 15;13(4):1133-9.

5.

Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients.

Zekri AR, El-Kassas M, Saad Y, Bahnassy A, El-Din HK, Darweesh SK, Abdel Hafez H, Esmat G.

Ann Hepatol. 2013 Sep-Oct;12(5):774-81.

6.

Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.

Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.

J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.

PMID:
19793164
7.

MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients.

Hussein YM, Morad FE, Gameel MA, Emam WA, El Sawy WH, El Tarhouny SA, Bayomy ES, Raafat N.

Med Oncol. 2012 Dec;29(5):3055-62. doi: 10.1007/s12032-012-0257-1. Epub 2012 Jun 1.

PMID:
22653756
8.

Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.

Omar H, Lim CR, Chao S, Lee MM, Bong CW, Ooi EJ, Yu CG, Tan SS, Abu Hassan MR, Menon J, Muthukaruppan R, Singh M, Nik Abdullah NA, Ooi BP, Ding RP, Low EJ, Tan F, Novak D, Harris DF, Yang H, Merican I, Liew CC.

J Clin Gastroenterol. 2015 Feb;49(2):150-7. doi: 10.1097/MCG.0000000000000112.

PMID:
25569223
9.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
10.

Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.

Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, Wu XH, Yao DB, Meng XY.

Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):288-95.

PMID:
18522884
11.

Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.

El-Mazny A, Sayed M, Sharaf S.

Arab J Gastroenterol. 2014 Jun;15(2):68-71. doi: 10.1016/j.ajg.2014.04.001. Epub 2014 Jun 10.

PMID:
25097049
12.

[Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].

Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF.

Zhonghua Wai Ke Za Zhi. 2006 Apr 1;44(7):458-62. Chinese.

PMID:
16772080
13.

Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.

Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D.

Ann Hepatol. 2011 Jul-Sep;10(3):296-305.

14.

Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.

Anticancer Res. 2013 Mar;33(3):1013-21.

PMID:
23482775
15.

Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?

Abdelgawad IA, Mossallam GI, Radwan NH, Elzawahry HM, Elhifnawy NM.

Asian Pac J Cancer Prev. 2013;14(12):7345-9.

16.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
17.

Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.

Ozkan H, Erdal H, Koçak E, Tutkak H, Karaeren Z, Yakut M, Köklü S.

J Clin Lab Anal. 2011;25(5):350-3. doi: 10.1002/jcla.20484.

PMID:
21919070
18.

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.

Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB.

Hepatology. 2002 Aug;36(2):410-7.

PMID:
12143050
19.

Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.

Wang W, Zhao LJ, Wang Y, Tao QY, Feitelson MA, Zhao P, Ren H, Qi ZT.

Cancer Biomark. 2011-2012;11(1):29-39. doi: 10.3233/CBM-2012-0261.

PMID:
22820138
20.

Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.

Zekri AR, Bahnassy AA, Abdel-Wahab SA, Khafagy MM, Loutfy SA, Radwan H, Shaarawy SM.

J Gastroenterol Hepatol. 2009 Mar;24(3):416-28. doi: 10.1111/j.1440-1746.2008.05699.x. Epub 2008 Nov 27.

PMID:
19054267

Supplemental Content

Support Center